Results 271 to 280 of about 628,141 (359)

Rare <i>SRRM2</i> mutation in neurodevelopmental disorders involving hyperphagia triggering severe obesity and other complication. [PDF]

Front Med (Lausanne)
Chang SH, Wang X, Jin JY, Wang Q, Wu LP.
europepmc   +1 more source

Metabolic syndrome and ADRB3 gene polymorphism in severely obese patients from South Italy [PDF]

, 2007
C Finelli, C Nardelli, F Contaldo, F Pasanisi, G Labruna, G Oriani, G Salvatori, L Sacchetti, P Buono, R Bracale   +9 more
core  

Cefuroxime axetil dosing regimens and probability of target attainment in adults and children

British Journal of Clinical Pharmacology, EarlyView.
Aims Cefuroxime axetil exists in several dosage forms for oral administration, and is indicated for treatment of respiratory, genitourinary, skin and soft tissue infections. Evolving patterns of bacterial susceptibility, expressed as increasing minimum inhibitory concentrations (MICs), warrant monitoring of antibiotic efficacy.
Sven C. van Dijkman, Praveen Kamble, Jerzy A. Kowalski, Oscar Della Pasqua   +3 more
wiley   +1 more source

What Is the Impact of Obesity-Related Comorbidities on the Risk of Premature Aging in Patients with Severe Obesity?: A Cross-Sectional Study. [PDF]

Medicina (Kaunas)
Dudek A, Zapała B, Gorostowicz A, Kawa I, Ciszek K, Tylec P, Cyranka K, Sierocki W, Wysocki M, Major P.   +9 more
europepmc   +1 more source

Intervention for Severely Obese Children and Adolescents

Journal of Obesity & Metabolic Syndrome, 2019
openaire   +5 more sources

Artificial intelligence modelling of tyrosine kinase inhibitors at risk of malabsorption and bioavailability‐enhancing strategies

British Journal of Clinical Pharmacology, EarlyView.
Aims The study aims to predict and improve the absorption of tyrosine kinase inhibitors (TKIs) in patients with malabsorption issues, particularly those who have undergone bariatric surgery or are using proton‐pump inhibitors. The research involves 2 main components: the development of an artificial intelligence (AI) model to identify TKIs that are ...
Daan W. Huntjens, Olivier J. M. Béquignon, Stefanie D. Krens, Mark Löwenberg, Martine E. D. Chamuleau, Remco J. Molenaar, Anita M. G. Kramers, Marianne A. Kuijvenhoven, Imke H. Bartelink   +8 more
wiley   +1 more source

A combination of drug, behavioral and surgical therapy to relieve from severe obesity complicated with multiple organs failure: A case report. [PDF]

Medicine (Baltimore)
Feng F, Zhang J, Gao Y, Ye Q, Wang G, Gu J, Peng L.   +6 more
europepmc   +1 more source

Evaluating Digital Rehabilitation Outcomes in Chronic Musculoskeletal Conditions Across Non-Obesity, Obesity, and Severe Obesity. [PDF]

J Pain Res
Pereira AP, Janela D, Areias AC, Molinos M, Tong X, Bento V, Yanamadala V, Cohen SP, Correia FD, Costa F.   +9 more
europepmc   +1 more source

Insight into the functional and structural relationship of ornithine decarboxylase and its mutants from Lacticaseibacillus rhamnosus

Bulletin of the Korean Chemical Society, EarlyView.
Structural and functional analysis of Lactaseibacillus rhamnosus ODC highlights a key residue influencing PLP binding, enzymatic activity, and crystal structure, providing insight into its catalytic mechanism. Abstract Ornithine decarboxylase (ODC) is a critical enzyme in the polyamine biosynthesis pathway that catalyzes the conversion of l‐ornithine ...
Nonvide Nicolas Adiko, Hyeon Tae Seo, Dae‐Won Ki, Jung Hee Park, Da Som Kim   +4 more
wiley   +1 more source

Associations between circulating amino acids and metabolic dysfunction-associated steatotic liver disease in individuals living with severe obesity. [PDF]

Physiol Rep
Maltais-Payette I, Bourgault J, Gauthier MF, Biertho L, Marceau S, Julien F, Mitchell PL, Couture C, Brière F, Corbeil J, Arsenault BJ, Tchernof A.   +11 more
europepmc   +1 more source